Theralase(R) Optimizes Phase II Bladder Cancer Clinical Study

Post Study II Monitoring of Response, Optional Maintenance Study II Treatments and Central Pathology Laboratory Review OptimizedTORONTO, ON / ACCESSWIRE / October 23, 2023 / Theralase Technologies Inc. ("Theralase" or the "Company") …